Summary Associations between the incidence of stromal and germ cell ovarian cancer and pregnancies were examined in a follow-up of 1.1 million women aged 20-56 years. Stromal tumours (41 cases) showed no clear associations. Germ cell tumours (71 cases) were related to high-age childbirths and short time since birth.
Several epidemiological studies have shown associations between epithelial ovarian cancer and reproductive factors. Few studies, however, have examined potential relations with other histological types of ovarian cancer. It has been hypothesized that epithelial ovarian cancer and ovarian cancer of stromal origin may have common risk factors (Cramer and Welch, 1983 ), but few studies have compared the two cancer types. Furthermore, it has been suggested that exposure to oestrogens in utero may be a risk factor for ovarian cancer of germ cell origin Walker et al, 1988) . If endogenous female sex hormones play a role in the aetiology of germ cell tumours, the very high levels of such hormones during pregnancy might also influence the risk of germ cell tumours for the mother.
The aim of the present study was to investigate the potential relations between the incidence of ovarian cancer of stromal and germ cell origin and the number of full-term pregnancies, age at first and last birth and time since last birth in a large cohort of Norwegian women. We have previously reported on relations between the risk of epithelial ovarian cancer and reproductive factors in the same data set (Albrektsen et al, 1996) .
MATERIALS AND METHODS
The present study includes all Norwegian women born in the period 1935-71 who had been residents of Norway for some period after 1960. This study population consists of 1 145 076 women, contributing a total of 18 813 445 person-years in the age interval 20-56 years during follow-up until 31 December 1991. The mean follow-up time per woman was 16.4 years (range 0.5 months to 36.9 years).
The reproductive history of each woman, with date of birth for each live-born child, was obtained from the Central Population Register at the Central Bureau of Statistics. The updated version of the file with information on demographic and reproductive characteristics (Albrektsen et al, 1994) 
Statistical analyses
Potential relations between the risk of ovarian cancer of stromal and germ cell origin and reproductive factors were examined in a log-linear Poisson regression model of person-years at risk (Breslow and Day, 1987) . In this context, a woman was considered to be at risk of developing ovarian cancer from the age of 20 years. Certain analyses included parous women only. Date of each delivery was recorded, and a woman contributed person-years in successive categories of attained age, number of full-term pregnancies, age at last birth and time since last birth. A woman was withdrawn from follow-up at the date of ovarian cancer diagnosis, emigration or death. Women with a diagnosis of ovarian cancer different from the histological classification under consideration (including epithelial ovarian cancer) were withdrawn at date of diagnosis.
All analyses were adjusted for attained age in 1-year intervals and birth cohort in 5-year intervals. In the statistical model, (Preston et al, 1993 (Table 3) .
DISCUSSION
Ovarian cancer of stromal and germ cell origin is rare, and few studies have investigated potential relationships with reproductive factors. The large cohort of Norwegian women considered here included enough cancer cases for estimation of overall associations, although risk estimates were imprecise. However, it was difficult to examine the relative importance of these highly correlated variables in joint analyses of several factors. We did not find any consistent relation with the number of fullterm pregnancies, neither for stromal nor germ cell tumours. In one previous study (Horn-Ross et al, 1992) , nulliparous women had a slightly higher risk of germ cell tumours and a slightly lower risk of stromal tumours than parous women. No trend was seen with increasing parity, however. A decrease in risk with increasing parity was found for both histological types in another study (Adami et al, 1994) . This study also included women aged 15-19 years, which may have led to different risk estimates.
Consistent with a previous report (Adami et al, 1994) , our data showed no clear relation between age at first birth and the risk of stromal tumours. In another study which included additional adjustment for use of oral contraceptives (Horn-Ross et al, 1992), a positive association was found. For germ cell tumours, we found an increase in risk with increasing age at first birth. In a previous study of germ cell tumours which adjusted for oral contraceptive use (Horn-Ross et al, 1992) and in another which did not (Adami et al, 1994) , no consistent association with age at first birth was observed.
Use of oral contraceptives may be related to an increased risk of germ cell tumours and a reduced risk of stromal tumours (Horn-Ross et al, 1992) . High age at first birth may be associated with use of oral contraceptives. In analyses not adjusted for oral contraceptive use, increasing age at first birth may thus be related to an apparent increase in risk of germ cell tumours and a decrease in risk of stromal tumours. Confounding by use of oral contraceptives cannot be ruled out in relation to our results for age at first birth.
Older age at last birth was associated with an elevated risk of germ cell tumours. Potential associations with age at last birth have not been investigated in previous studies. We also found an elevated risk of germ cell tumours shortly after birth. Among women of the same category of attained age, those with a late last birth are also characterized by shorter time since last birth. Thus, the positive association with age at last birth may explain the negative association with time since last birth in relation to the risk of germ cell tumours, or vice versa. However, because of the small number of cancer cases, it was not possible to investigate the relative importance of age at last birth and time since last birth using the method applied previously for epithelial tumours (Albrektsen et al, 1996) .
It has been suggested that the aetiology of germ cell tumours in women is similar to that of testicular germ cell cancer (Walker et al, 1984; Henderson et al, 1988; Walker et al, 1988; Westhoff et al, 1988; dos Santos Silva and Swerdlow, 1991) . Thus, oestrogen exposure may represent an initiation role in utero, and gonadotropins may have a promoting effect in early adulthood Walker et al, 1988; dos Santos Silva and Swerdlow, 1991) . No information regarding in utero exposure was available in the present study. However, the elevated risk immediately after birth indicates that female sex hormones during pregnancy may influence the risk of germ cell tumours, presumably acting as promoting factors.
Compared with other types of ovarian cancer, germ cell tumours were common among women in the age group 10-19 years (43.7% of all germ cell tumours in this study). Because in this group most women are nulliparous, our analyses were restricted to the age interval 20-56 years. During puberty and early adulthood, large hormonal changes occur which may affect the risk of germ cell tumours among nulliparous women below the age of 20 years.
The age distribution of women with stromal tumours was similar to that of women with epithelial ovarian cancer. As with epithelial ovarian cancer (Albrektsen et al, 1996) , increasing age at last birth was associated with a decrease in risk of stromal tumours, although not significantly. In contrast to epithelial tumours, however, no consistent association was seen with number of births. Furthermore, whereas the risk of epithelial ovarian cancer increased with increasing time since last birth (Albrektsen et al, 1996) , a negative association was suggested for stromal tumours. Thus, in agreement with a previous report (Horn-Ross et al, 1992) our results indicate that the associations between reproductive factors and ovarian cancer of both stromal and germ cell origin differ from those for epithelial ovarian cancer.
